ClinicalTrials.Veeva

Menu

The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Premature Rupture of Membrane

Treatments

Diagnostic Test: assessment of beta subunit of human chorionic gonadotropin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Two groups will be recruited. The first group are pregnant ladies that have unequivocal rupture of fetal membranes that is diagnosed by seeing the amniotic fluid leakage in the vagina. The second group are normal pregnant ladies without rupture of membranes. both groups will be tested by taking vaginal washing fluid. Quantitative and qualitative pregnancy tests will be measured in this fluid.

Full description

Beta subunit of human chorionic gonadotropin assay will be measured in the vaginal washing in two groups. The first group are pregnant women in the second or third trimester. These women have definite rupture of membranes diagnosed by visual leaking of the amniotic fluid from the cervix during speculum examination. The second group are pregnant women with intact membranes. Assessment of both the qualitative and quantitative beta subunit of human chorionic gonadotropin will be done

Enrollment

100 patients

Sex

Female

Ages

17 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women between 14 and 40 weeks gestation with history of gush of vaginal fluid
  • Pregnant women between without history of gush of vaginal fluid

Exclusion criteria

  • Presence of vaginal bleeding
  • Presence of any obstetric emergency as cord prolapse

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Rupture of membranes group
Active Comparator group
Description:
Pregnant women with definite rupture of membranes will undergo speculum examination. Vaginal washing will be done. The washing fluid will be taken for quantitative and qualitative assessment of beta subunit of human chorionic gonadotropin.
Treatment:
Diagnostic Test: assessment of beta subunit of human chorionic gonadotropin
Intact membranes group
Active Comparator group
Description:
Pregnant women with intact membranes will undergo speculum examination. Vaginal washing will be done. The washing fluid will be taken for quantitative and qualitative assessment of beta subunit of human chorionic gonadotropin.
Treatment:
Diagnostic Test: assessment of beta subunit of human chorionic gonadotropin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems